Noninvasive volume-assured pressure support for chronic respiratory failure: A review

Gaja F. Shaughnessy, Peter C. Gay, Eric J. Olson, Timothy I. Morgenthaler

Research output: Contribution to journalArticle

Abstract

Purpose of reviewNoninvasive ventilation (NIV) is an established treatment for chronic hypercapnic respiratory failure (CRF). Volume-assured pressure support (VAPS) is a mode of NIV that automatically adjusts inspiratory pressure in order to maintain a constant respiratory volume. We aim to discuss the role and application of VAPS in CRF.Recent findingsRecently published meta-analyses and reviews fail to demonstrate a significant difference in gas exchange, sleep, or quality-of-life improvement between VAPS and bilevel positive airway pressure (BPAP) in patients with CRF. A recent manuscript suggests that VAPS therapy in chronic obstructive pulmonary disease patients may reduce the number of exacerbations. It has been shown that with a protocol-driven approach BPAP and VAPS can both be successfully titrated during a single split-night polysomnography.SummaryVAPS is as effective as other modes of NIV at improving ventilation and sleep in CRF. The potential advantage is a more consistent ventilatory support through daytime-nighttime variations and progression of disease over time. However, the impact on long-term outcomes, such as survival, has not been studied.

Original languageEnglish (US)
Pages (from-to)570-577
Number of pages8
JournalCurrent opinion in pulmonary medicine
Volume25
Issue number6
DOIs
StatePublished - Nov 1 2019

Fingerprint

Respiratory Insufficiency
Pressure
Ventilation
Sleep
Manuscripts
Polysomnography
Quality Improvement
Chronic Obstructive Pulmonary Disease
Disease Progression
Meta-Analysis
Gases
Quality of Life
Survival
Therapeutics

Keywords

  • chronic respiratory failure
  • noninvasive ventilation
  • volume-assured pressure support

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Noninvasive volume-assured pressure support for chronic respiratory failure : A review. / Shaughnessy, Gaja F.; Gay, Peter C.; Olson, Eric J.; Morgenthaler, Timothy I.

In: Current opinion in pulmonary medicine, Vol. 25, No. 6, 01.11.2019, p. 570-577.

Research output: Contribution to journalArticle

@article{b30a43542bf2423d92de42e6d3842f9f,
title = "Noninvasive volume-assured pressure support for chronic respiratory failure: A review",
abstract = "Purpose of reviewNoninvasive ventilation (NIV) is an established treatment for chronic hypercapnic respiratory failure (CRF). Volume-assured pressure support (VAPS) is a mode of NIV that automatically adjusts inspiratory pressure in order to maintain a constant respiratory volume. We aim to discuss the role and application of VAPS in CRF.Recent findingsRecently published meta-analyses and reviews fail to demonstrate a significant difference in gas exchange, sleep, or quality-of-life improvement between VAPS and bilevel positive airway pressure (BPAP) in patients with CRF. A recent manuscript suggests that VAPS therapy in chronic obstructive pulmonary disease patients may reduce the number of exacerbations. It has been shown that with a protocol-driven approach BPAP and VAPS can both be successfully titrated during a single split-night polysomnography.SummaryVAPS is as effective as other modes of NIV at improving ventilation and sleep in CRF. The potential advantage is a more consistent ventilatory support through daytime-nighttime variations and progression of disease over time. However, the impact on long-term outcomes, such as survival, has not been studied.",
keywords = "chronic respiratory failure, noninvasive ventilation, volume-assured pressure support",
author = "Shaughnessy, {Gaja F.} and Gay, {Peter C.} and Olson, {Eric J.} and Morgenthaler, {Timothy I.}",
year = "2019",
month = "11",
day = "1",
doi = "10.1097/MCP.0000000000000605",
language = "English (US)",
volume = "25",
pages = "570--577",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Noninvasive volume-assured pressure support for chronic respiratory failure

T2 - A review

AU - Shaughnessy, Gaja F.

AU - Gay, Peter C.

AU - Olson, Eric J.

AU - Morgenthaler, Timothy I.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Purpose of reviewNoninvasive ventilation (NIV) is an established treatment for chronic hypercapnic respiratory failure (CRF). Volume-assured pressure support (VAPS) is a mode of NIV that automatically adjusts inspiratory pressure in order to maintain a constant respiratory volume. We aim to discuss the role and application of VAPS in CRF.Recent findingsRecently published meta-analyses and reviews fail to demonstrate a significant difference in gas exchange, sleep, or quality-of-life improvement between VAPS and bilevel positive airway pressure (BPAP) in patients with CRF. A recent manuscript suggests that VAPS therapy in chronic obstructive pulmonary disease patients may reduce the number of exacerbations. It has been shown that with a protocol-driven approach BPAP and VAPS can both be successfully titrated during a single split-night polysomnography.SummaryVAPS is as effective as other modes of NIV at improving ventilation and sleep in CRF. The potential advantage is a more consistent ventilatory support through daytime-nighttime variations and progression of disease over time. However, the impact on long-term outcomes, such as survival, has not been studied.

AB - Purpose of reviewNoninvasive ventilation (NIV) is an established treatment for chronic hypercapnic respiratory failure (CRF). Volume-assured pressure support (VAPS) is a mode of NIV that automatically adjusts inspiratory pressure in order to maintain a constant respiratory volume. We aim to discuss the role and application of VAPS in CRF.Recent findingsRecently published meta-analyses and reviews fail to demonstrate a significant difference in gas exchange, sleep, or quality-of-life improvement between VAPS and bilevel positive airway pressure (BPAP) in patients with CRF. A recent manuscript suggests that VAPS therapy in chronic obstructive pulmonary disease patients may reduce the number of exacerbations. It has been shown that with a protocol-driven approach BPAP and VAPS can both be successfully titrated during a single split-night polysomnography.SummaryVAPS is as effective as other modes of NIV at improving ventilation and sleep in CRF. The potential advantage is a more consistent ventilatory support through daytime-nighttime variations and progression of disease over time. However, the impact on long-term outcomes, such as survival, has not been studied.

KW - chronic respiratory failure

KW - noninvasive ventilation

KW - volume-assured pressure support

UR - http://www.scopus.com/inward/record.url?scp=85072904833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072904833&partnerID=8YFLogxK

U2 - 10.1097/MCP.0000000000000605

DO - 10.1097/MCP.0000000000000605

M3 - Article

C2 - 31306163

AN - SCOPUS:85072904833

VL - 25

SP - 570

EP - 577

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 6

ER -